Bone Loss and Fracture Risk in Patients With HIV

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective ...

Expert Insights on Aging With HIV

Three HIV experts provide their insights into aging-related challenges and complications faced by people living with HIV.

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to ART and PrEP.

Community Perspective on HIV Research at the End of Life

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

HIV Transmission Through Breastfeeding

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

Latest News

Single Measure Viral Load Estimates of HIV Suppression in 2014

Single Measure Viral Load Estimates of HIV Suppression in 2014

Single measures of viral load can overestimate how many individuals with HIV infection have viral suppression.

Hepatitis B, Hepatitis C, HIV More Common in Severe Mental Illness

Hepatitis B, Hepatitis C, HIV More Common in Severe Mental Illness

HIV, hepatitis B, and hepatitis C infections are more prevalent among patients with severe mental illness than in the general population.

Point-of-Care Tests for HIV and T pallidum Infections: Utility of Smartphone-Based Electronic Reader

Point-of-Care Tests for HIV and T pallidum Infections: Utility of Smartphone-Based Electronic Reader

A smartphone-based electronic reader with dual point of care tests were evaluated in the detection of antibodies to T pallidum and HIV.

Offering Rapid HIV Testing in EDs Increase Testing Rates

Offering Rapid HIV Testing in EDs Increase Testing Rates

Rapid HIV testing offered to patients in addition to a clinician consultation increases the testing rate in the emergency department.

Viral Load Rebound Seen After HIV Suppression in Pregnancy

Viral Load Rebound Seen After HIV Suppression in Pregnancy

Women achieving HIV viral suppression in pregnancy can experience viral load rebound predelivery.

FDA Expands Epclusa® Indication for HCV/HIV Co-infection

FDA Expands Epclusa® Indication for HCV/HIV Co-infection

The FDA has approved an expanded indication for Epclusa to include the use of this once-daily single tablet regimen in patients co-infected with chronic hepatitis C virus and HIV.

HIV Status May Not Effect Incidence of Invasive Cervical Cancer

HIV Status May Not Effect Incidence of Invasive Cervical Cancer

HIV infection may not contribute to incidence of invasive cervical cancer.

FDA Grants Priority Review to Single Tablet HIV Regimen

FDA Grants Priority Review to Single Tablet HIV Regimen

The FDA has granted Priority Review to the New Drug Application for Gilead's investigational single-tablet regimen in the treatment of HIV-1 infection.

Penile Microbiome Linked to Increased HIV Risk in Heterosexual Partners

Penile Microbiome Linked to Increased HIV Risk in Heterosexual Partners

The microbiome of the area on the penis located under the foreskin in uncircumcised straight men has been linked to increased risk for contracting HIV.

Antiretroviral Therapy Associated With Decreases in Bone Mineral Density

Antiretroviral Therapy Associated With Decreases in Bone Mineral Density

Patients with HIV undergoing antiretroviral therapy saw significant decreases in bone mineral density.

Feature Article

ART and PrEP: How Technological Advances Can Improve Adherence

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to antiretroviral and preexposure prophylaxis therapy.

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

PrEP in the Transgender Population: New Study to Examine Effects

PrEP in the Transgender Population: New Study to Examine Effects

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.

Cardiovascular Disease in Persons With HIV Infection

Cardiovascular Disease in Persons With HIV Infection

Persons living with HIV infection have a higher risk for cardiovascular disease; use of some antiretroviral agents can exacerbate this risk.

Should the FDA Lift the Ban on Blood Donations From MSM?

Should the FDA Lift the Ban on Blood Donations From MSM?

Critics of the FDA's current restriction on blood donation from MSM argue that it is unnecessary and discriminatory, and propose a policy based on individual risk rather than sexual orientation.

HIV Research in Women: Expert Q&A

HIV Research in Women: Expert Q&A

Drs Gianella and Karris discuss the many factors that play a role in the underrepresentation of women in HIV research.

Confronting Coronary Heart Disease in HIV/AIDS

Confronting Coronary Heart Disease in HIV/AIDS

A review of coronary heart disease in patients with HIV.

HIV Care Continuum: Improving Future Outcomes

HIV Care Continuum: Improving Future Outcomes

While 86% of all persons living with HIV in the US know that they are HIV-infected, only an estimated 35% actually achieve viral suppression.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS